Luye Pharma Group Ltd. | Cash Flow
Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
483
913
1,108
1,139
1,287
1,745
Depreciation, Depletion & Amortization
127
133
136
158
281
368
Other Funds
236
10
6
5
6
183
Funds from Operations
510
922
1,099
1,189
1,353
1,931
Changes in Working Capital
48
473
508
355
12
34
Net Operating Cash Flow
559
449
590
834
1,364
1,896
Capital Expenditures
342
349
257
373
721
Sale of Fixed Assets & Businesses
-
1
32
865
1
Purchase/Sale of Investments
13
2,799
421
22
287
Net Investing Cash Flow
703
4,023
190
2,256
983
Cash Dividends Paid - Total
-
-
-
125
245
Issuance/Reduction of Debt, Net
346
553
243
1,310
1,427
Net Financing Cash Flow
110
3,282
238
1,180
646
Net Change in Cash
39
291
1,025
269
930
Free Cash Flow
224
111
339
526
779
Net Assets from Acquisitions
-
881
-
1,957
6
Other Sources
32
-
3
1,126
1,472
Change in Capital Stock
-
3,845
-
-
530
Exchange Rate Effect
4
1
7
27
98
Other Uses
382
26
-
1,075
1,441
About Luye Pharma Group
View Profile
